Adil Irani, MD
Cardiovascular Disease (Cardiology) · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 7 carriers
- Offices
- 2
- Since medical school
- 34 years
- Graduated 1992
Offices
2 locations · California Cardiovascular Consultants · Washington Township Hospital District
Looking this up.
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
30 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Irani’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75847 · Current
Licensed to practise in California · since 2001 · expires 2027-04-30 · Shivaji University, Krishna Institute of Medical Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Nuclear Medicine - Nuclear Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$90,711
Medicare paid this office $90,711 for 1,073 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $26,272 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 354 | $20,293 | $54 |
| Return visit (30+ min) | 66 | $13,605 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $8,895 | $120 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24 | $4,675 | $180 |
See all 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $26,272 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 354 | $20,293 | $54 |
| Return visit (30+ min) | 66 | $13,605 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $8,895 | $120 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24 | $4,675 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 627 | $4,573 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,498 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,348 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $150 | $12 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 25 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,073 Original Medicare patients in 2024. Average age 78 · Under 65 8% · 85 and older 29% · Women 57% · Also on Medicaid 63% · Health risk score 2.42. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 58% · Coronary heart disease 52% · Chronic kidney disease 46% · Heart failure 45% · Atrial fibrillation 38% · COPD 25% · Dementia 25% · Stroke 23% · Depression 22% · Cancer 17%.
The office billed $293,715, Medicare allowed $123,286 and paid $90,711; for 1,773 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,073 | 1,773 | 78 | 2.42 | $293,715 | $90,711 |
| 2023 | 982 | 1,618 | 78 | 2.13 | $261,801 | $87,285 |
| 2022 | 1,279 | 2,287 | 77 | 2.26 | $361,888 | $107,486 |
| 2021 | 797 | 1,635 | 77 | 2.37 | $302,852 | $109,981 |
| 2020 | 792 | 1,813 | 76 | 2.63 | $310,077 | $110,545 |
| 2019 | 1,119 | 2,514 | 77 | 2.56 | $474,041 | $167,568 |
| 2018 | 1,213 | 3,011 | 77 | 2.42 | $549,883 | $190,097 |
| 2017 | 869 | 2,597 | 77 | 2.63 | $538,830 | $194,636 |
| 2016 | 875 | 2,381 | 77 | 2.57 | $414,814 | $128,233 |
| 2015 | 759 | 2,283 | 76 | 2.63 | $467,903 | $146,446 |
| 2014 | 780 | 2,394 | 76 | 2.33 | $464,860 | $154,840 |
| 2013 | 580 | 1,892 | 75 | 2.50 | $473,861 | $152,476 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $22,890 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 309 | $18,889 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $12,979 | $146 |
| Return visit (30+ min) | 66 | $11,227 | $106 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $5,295 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 590 | $5,019 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $167 | $14 |
2022: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 300 | $19,448 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $18,381 | $178 |
| Return visit (30+ min) | 84 | $17,915 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $13,025 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 883 | $7,409 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 31 | $5,345 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $4,466 | $65 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,540 | $295 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $164 | $11 |
2021: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $22,007 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $19,167 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 280 | $18,458 | $63 |
| Return visit (30+ min) | 89 | $18,245 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $6,833 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $4,467 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 406 | $3,488 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 19 | $1,363 | $72 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $136 | $11 |
2020: 15 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 340 | $24,110 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $20,884 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $10,528 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $7,917 | $198 |
| Return visit (30+ min) | 63 | $7,119 | $91 |
| Short return visit (20+ min) | 72 | $5,684 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $5,663 | $67 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $5,638 | $470 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 320 | $2,652 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,488 | $191 |
| New patient visit (45+ min) | 12 | $1,633 | $136 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | $1,155 | $96 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $806 | $73 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $790 | $61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $149 | $11 |
2019: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 479 | $32,561 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 157 | $29,950 | $180 |
| Short return visit (20+ min) | 122 | $14,196 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $13,012 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $12,830 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $12,523 | $482 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $10,651 | $205 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,604 | $475 |
| Return visit (30+ min) | 50 | $5,401 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 475 | $4,164 | $7 |
| New patient visit (45+ min) | 26 | $3,413 | $131 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,261 | $272 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,833 | $177 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 25 | $2,723 | $109 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 26 | $2,481 | $95 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $1,648 | $72 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 17 | $1,020 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $553 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $306 | $11 |
| Ultrasound of heart, follow-up | 12 | $303 | $23 |
2018: 18 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 206 | $37,584 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 431 | $27,460 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 126 | $23,983 | $87 |
| Return visit (30+ min) | 134 | $19,445 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $15,038 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 60 | $12,065 | $195 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $9,789 | $466 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $9,191 | $418 |
| Short return visit (20+ min) | 84 | $8,156 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 623 | $5,210 | $7 |
| New patient visit (45+ min) | 25 | $3,265 | $131 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $2,884 | $240 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,275 | $175 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 21 | $2,135 | $89 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $1,603 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 13 | $729 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 46 | $690 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $288 | $10 |
2017: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $42,040 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 188 | $35,180 | $167 |
| Return visit (30+ min) | 133 | $23,475 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $18,208 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 298 | $17,360 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 47 | $10,266 | $214 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $9,771 | $444 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 435 | $5,432 | $11 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,010 | $455 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,222 | $268 |
| Critical care, first 30-74 minutes | 12 | $3,139 | $185 |
| New patient visit (45+ min) | 22 | $2,963 | $135 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $2,488 | $67 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 17 | $1,761 | $104 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $1,694 | $154 |
| Short return visit (20+ min) | 24 | $1,670 | $46 |
| Review by radiologist of arm or leg artery image | 18 | $827 | $46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $462 | $14 |
2016: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 137 | $34,950 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 149 | $25,614 | $160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 260 | $14,428 | $54 |
| Short return visit (20+ min) | 76 | $8,822 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $7,953 | $209 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,363 | $488 |
| Return visit (30+ min) | 48 | $5,357 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 528 | $4,655 | $7 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,169 | $288 |
| New patient visit (45+ min) | 16 | $2,045 | $128 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $1,941 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,117 | $86 |
| Review by radiologist of arm or leg artery image | 21 | $973 | $46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $531 | $15 |
2015: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $42,523 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 167 | $31,195 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $16,660 | $55 |
| Short return visit (20+ min) | 83 | $9,514 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $6,479 | $223 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $6,205 | $214 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,540 | $504 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 64 | $4,634 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 369 | $3,281 | $7 |
| Return visit (30+ min) | 25 | $2,483 | $92 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,351 | $157 |
| New patient visit (45+ min) | 13 | $1,694 | $130 |
| Review by radiologist of arm or leg artery image | 31 | $1,547 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,521 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $352 | $15 |
2014: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 186 | $35,932 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 147 | $28,787 | $171 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 386 | $22,769 | $56 |
| Short return visit (20+ min) | 98 | $12,797 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $9,063 | $227 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,735 | $516 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $5,049 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 69 | $4,861 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 274 | $2,688 | $7 |
| New patient visit (45+ min) | 18 | $2,633 | $146 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,424 | $173 |
| Return visit (30+ min) | 22 | $2,255 | $98 |
| Initial hospital observation care per day, typically 70 minutes | 14 | $1,866 | $133 |
| Review by radiologist of arm or leg artery image | 23 | $1,114 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $449 | $14 |
2013: 17 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 191 | $38,001 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 156 | $30,809 | $170 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 325 | $18,776 | $55 |
| Short return visit (20+ min) | 93 | $12,796 | $60 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $9,483 | $474 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 78 | $5,176 | $66 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $4,777 | $299 |
| Initial hospital observation care per day, typically 70 minutes | 24 | $3,655 | $152 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $3,599 | $180 |
| Return visit (30+ min) | 28 | $2,687 | $93 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,506 | $209 |
| New patient visit (45+ min) | 14 | $2,125 | $152 |
| Review by radiologist of arm or leg artery image | 26 | $1,270 | $47 |
| Drug infusion during cardiac catheterization | 12 | $1,174 | $90 |
| Review by radiologist of both arms or legs arteries image | 15 | $937 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 94 | $826 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $325 | $17 |
Medicaid work
$13,442 in 2024
Medicaid paid $13,442 for 948 billed services this clinician did in 2024, up to 170 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 299 | $6,193 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 579 | $5,696 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 49 | $894 |
| 1ST HOSP IP/OBS HIGH 75 | 21 | $659 |
| 2024 | 948 | 4 | 170 | $13,442 |
| 2023 | 1,116 | 4 | 166 | $12,820 |
| 2022 | 1,398 | 4 | 182 | $17,939 |
| 2021 | 935 | 5 | 165 | $14,635 |
| 2020 | 693 | 5 | 115 | $11,236 |
| 2019 | 1,098 | 4 | 142 | $14,774 |
| 2018 | 1,186 | 5 | 124 | $15,251 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 362 | $6,296 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 684 | $4,697 |
| 1ST HOSP IP/OBS HIGH 75 | 56 | $1,659 |
| Return visit (30+ min) | 14 | $168 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 328 | $8,038 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 965 | $6,897 |
| Return visit (30+ min) | 57 | $1,641 |
| 1ST HOSP IP/OBS HIGH 75 | 48 | $1,363 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 341 | $8,884 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 492 | $3,617 |
| 1ST HOSP IP/OBS HIGH 75 | 66 | $1,955 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 24 | $179 |
| Return visit (30+ min) | 12 | $0 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 336 | $8,334 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 303 | $2,050 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $546 |
| Short return visit (20+ min) | 25 | $239 |
| Return visit (30+ min) | 14 | $67 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 538 | $10,178 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 429 | $2,778 |
| 1ST HOSP IP/OBS HIGH 75 | 54 | $1,020 |
| Short return visit (20+ min) | 77 | $798 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 481 | $8,270 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 505 | $3,255 |
| 1ST HOSP IP/OBS HIGH 75 | 151 | $2,730 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $714 |
| Return visit (30+ min) | 14 | $282 |
Drugs they prescribed that Part D paid
$214,455
Pharmacies billed $214,455 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,177) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
963 generic and 214 brand-name prescriptions · $214,455 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 71 | $85,259 | $1,201 |
| Entresto | 19 | $25,743 | $1,355 |
| Farxiga | 22 | $21,298 | $968 |
| Jardiance | 20 | $19,466 | $973 |
| Verquvo | 12 | $16,162 | $1,347 |
See all 28 drugs
| Eliquis | 71 | $85,259 | $1,201 |
| Entresto | 19 | $25,743 | $1,355 |
| Farxiga | 22 | $21,298 | $968 |
| Jardiance | 20 | $19,466 | $973 |
| Verquvo | 12 | $16,162 | $1,347 |
| Repatha Sureclick | 15 | $8,123 | $542 |
| Brilinta | 12 | $6,155 | $513 |
| Vascepa | 12 | $2,090 | $174 |
| Losartan | 96 | $1,218 | $13 |
| Atorvastatin | 120 | $989 | $8 |
| Diltiazem 24hr Er (Cd) | 24 | $895 | $37 |
| Rosuvastatin | 33 | $870 | $26 |
| Metoprolol | 65 | $775 | $12 |
| Amlodipine Besylate | 78 | $706 | $9 |
| Isosorbide Dinitrate | 21 | $641 | $31 |
| Ezetimibe | 28 | $559 | $20 |
| Carvedilol | 64 | $452 | $7 |
| Clopidogrel | 45 | $450 | $10 |
| Hydralazine | 34 | $432 | $13 |
| Digoxin | 18 | $349 | $19 |
| Furosemide | 52 | $316 | $6 |
| Metoprolol | 24 | $237 | $10 |
| Lisinopril | 34 | $235 | $7 |
| Diltiazem | 13 | $218 | $17 |
| Pravastatin | 26 | $205 | $8 |
| Spironolactone | 49 | $187 | $4 |
| Nitroglycerin | 15 | $160 | $11 |
| Hydrochlorothiazide | 15 | $151 | $10 |
Year by year
| 2024 | 1,177 | 127 | 0% (0) | 18% | $214,455 |
| 2023 | 1,286 | 129 | 0% (0) | None | $189,548 |
| 2022 | 1,263 | 129 | 0% (0) | None | $155,814 |
| 2021 | 1,659 | 154 | 0% (0) | 15% | $156,166 |
| 2020 | 1,800 | 164 | 0% (0) | 21% | $183,355 |
| 2019 | 1,623 | 182 | None | 22% | $160,415 |
| 2018 | 1,796 | 174 | None | 16% | $135,189 |
| 2017 | 1,412 | 132 | None | 17% | $91,691 |
| 2016 | 1,050 | 99 | 0% (0) | 13% | $47,182 |
| 2015 | 1,077 | 97 | None | 17% | $45,560 |
| 2014 | 1,321 | 112 | None | 20% | $77,797 |
| 2013 | 1,325 | 105 | None | 18% | $53,545 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Eliquis | 133 | $112,980 | $849 |
| Entresto | 15 | $17,937 | $1,196 |
| Brilinta | 12 | $13,994 | $1,166 |
| Vascepa | 11 | $2,109 | $192 |
| Atorvastatin | 118 | $2,086 | $18 |
| Isosorbide Dinitrate | 26 | $1,949 | $75 |
| Bumetanide | 47 | $1,944 | $41 |
| Rosuvastatin | 35 | $1,858 | $53 |
| Losartan | 98 | $1,815 | $19 |
| Diltiazem 24hr Er (Cd) | 31 | $1,715 | $55 |
| Amlodipine Besylate | 90 | $1,475 | $16 |
| Metoprolol | 80 | $1,429 | $18 |
| Carvedilol | 89 | $948 | $11 |
| Clopidogrel | 42 | $777 | $19 |
| Digoxin | 27 | $708 | $26 |
| Isosorbide Mononitrate Er | 18 | $687 | $38 |
| Diltiazem | 15 | $659 | $44 |
| Metoprolol | 45 | $636 | $14 |
| Nitroglycerin | 19 | $571 | $30 |
| Lisinopril | 47 | $411 | $9 |
| Pravastatin | 21 | $405 | $19 |
| Spironolactone | 41 | $292 | $7 |
| Furosemide | 43 | $262 | $6 |
| Clonidine | 12 | $223 | $19 |
| Hydrochlorothiazide | 17 | $213 | $13 |
| Enalapril Maleate | 12 | $123 | $10 |
2022: 28 drugs
| Eliquis | 118 | $89,859 | $762 |
| Entresto | 15 | $13,715 | $914 |
| Brilinta | 11 | $13,562 | $1,233 |
| Xarelto | 17 | $10,257 | $603 |
| Pradaxa | 13 | $6,950 | $535 |
| Isosorbide Dinitrate | 21 | $1,821 | $87 |
| Atorvastatin | 137 | $1,421 | $10 |
| Bumetanide | 20 | $1,380 | $69 |
| Rosuvastatin | 20 | $1,375 | $69 |
| Diltiazem 24hr Er (Cd) | 36 | $1,167 | $32 |
| Losartan | 126 | $1,166 | $9 |
| Amlodipine Besylate | 91 | $883 | $10 |
| Hydralazine | 30 | $782 | $26 |
| Carvedilol | 90 | $778 | $9 |
| Metoprolol | 54 | $700 | $13 |
| Nitroglycerin | 24 | $568 | $24 |
| Clopidogrel | 22 | $498 | $23 |
| Lisinopril | 41 | $467 | $11 |
| Digoxin | 23 | $346 | $15 |
| Metoprolol | 52 | $252 | $5 |
| Isosorbide Mononitrate Er | 16 | $233 | $15 |
| Levothyroxine | 14 | $221 | $16 |
| Furosemide | 43 | $192 | $4 |
| Spironolactone | 27 | $190 | $7 |
| Hydrochlorothiazide | 32 | $113 | $4 |
| Atenolol | 13 | $97 | $7 |
| Ramipril | 15 | $65 | $4 |
| Warfarin | 18 | $54 | $3 |
2021: 31 drugs
| Eliquis | 133 | $85,758 | $645 |
| Brilinta | 19 | $14,885 | $783 |
| Entresto | 16 | $10,266 | $642 |
| Xarelto | 11 | $7,676 | $698 |
| Pradaxa | 14 | $6,496 | $464 |
| Isosorbide Dinitrate | 87 | $5,096 | $59 |
| Atorvastatin | 183 | $1,999 | $11 |
| Vascepa | 11 | $1,843 | $168 |
| Losartan | 155 | $1,838 | $12 |
| Bumetanide | 16 | $1,486 | $93 |
| Diltiazem 24hr Er (Cd) | 39 | $1,312 | $34 |
| Carvedilol | 159 | $1,043 | $7 |
| Amlodipine Besylate | 123 | $895 | $7 |
| Hydralazine | 54 | $873 | $16 |
| Metoprolol | 61 | $858 | $14 |
| Rosuvastatin | 16 | $673 | $42 |
| Nitroglycerin | 28 | $564 | $20 |
| Digoxin | 31 | $401 | $13 |
| Clopidogrel | 31 | $373 | $12 |
| Metoprolol | 54 | $348 | $6 |
| Isosorbide Mononitrate Er | 17 | $254 | $15 |
| Lisinopril | 42 | $250 | $6 |
| Furosemide | 71 | $236 | $3 |
| Diltiazem | 15 | $205 | $14 |
| Warfarin | 37 | $189 | $5 |
| Spironolactone | 28 | $167 | $6 |
| Enalapril Maleate | 11 | $148 | $13 |
| Hydrochlorothiazide | 30 | $133 | $4 |
| Pantoprazole | 13 | $118 | $9 |
| Ramipril | 11 | $93 | $8 |
| Clonidine | 14 | $65 | $5 |
2020: 32 drugs
| Eliquis | 167 | $100,668 | $603 |
| Brilinta | 37 | $22,850 | $618 |
| Entresto | 20 | $16,949 | $847 |
| Pradaxa | 19 | $8,850 | $466 |
| Isosorbide Dinitrate | 75 | $3,542 | $47 |
| Atorvastatin | 179 | $2,193 | $12 |
| Vascepa | 12 | $1,984 | $165 |
| Losartan | 153 | $1,660 | $11 |
| Diltiazem 24hr Er (Cd) | 41 | $1,539 | $38 |
| Bumetanide | 13 | $1,121 | $86 |
| Valsartan | 17 | $1,102 | $65 |
| Metoprolol | 62 | $922 | $15 |
| Diltiazem 24hr Er | 25 | $875 | $35 |
| Carvedilol | 165 | $833 | $5 |
| Rosuvastatin | 11 | $807 | $73 |
| Metoprolol | 90 | $648 | $7 |
| Hydralazine | 48 | $604 | $13 |
| Clopidogrel | 63 | $591 | $9 |
| Nitroglycerin | 37 | $589 | $16 |
| Digoxin | 22 | $563 | $26 |
| Amlodipine Besylate | 114 | $539 | $5 |
| Diltiazem | 30 | $400 | $13 |
| Isosorbide Mononitrate Er | 29 | $383 | $13 |
| Warfarin | 48 | $349 | $7 |
| Levothyroxine | 16 | $341 | $21 |
| Lisinopril | 46 | $286 | $6 |
| Telmisartan | 11 | $279 | $25 |
| Furosemide | 69 | $274 | $4 |
| Spironolactone | 37 | $230 | $6 |
| Enalapril Maleate | 13 | $148 | $11 |
| Famotidine | 14 | $54 | $4 |
| Hydrochlorothiazide | 19 | $50 | $3 |
2019: 27 drugs
| Eliquis | 135 | $79,030 | $585 |
| Entresto | 42 | $21,981 | $523 |
| Brilinta | 39 | $19,681 | $505 |
| Pradaxa | 17 | $7,409 | $436 |
| Atorvastatin | 172 | $2,548 | $15 |
| Isosorbide Dinitrate | 57 | $2,416 | $42 |
| Metoprolol | 64 | $1,578 | $25 |
| Losartan | 148 | $1,453 | $10 |
| Diltiazem 24hr Er (Cd) | 37 | $1,311 | $35 |
| Bumetanide | 11 | $1,210 | $110 |
| Diltiazem | 38 | $883 | $23 |
| Carvedilol | 115 | $774 | $7 |
| Metoprolol | 85 | $742 | $9 |
| Isosorbide Mononitrate Er | 30 | $667 | $22 |
| Digoxin | 29 | $652 | $22 |
| Amlodipine Besylate | 89 | $649 | $7 |
| Clopidogrel | 68 | $616 | $9 |
| Lisinopril | 56 | $549 | $10 |
| Furosemide | 86 | $461 | $5 |
| Nitroglycerin | 15 | $382 | $25 |
| Hydralazine | 16 | $350 | $22 |
| Warfarin | 34 | $312 | $9 |
| Levothyroxine | 12 | $295 | $25 |
| Spironolactone | 38 | $231 | $6 |
| Famotidine | 21 | $109 | $5 |
| Hydrochlorothiazide | 13 | $80 | $6 |
| Atenolol | 11 | $72 | $7 |
2018: 30 drugs
| Eliquis | 92 | $47,981 | $522 |
| Brilinta | 41 | $25,073 | $612 |
| Entresto | 24 | $14,519 | $605 |
| Xarelto | 13 | $8,069 | $621 |
| Pradaxa | 16 | $7,095 | $443 |
| Atorvastatin | 207 | $3,066 | $15 |
| Isosorbide Dinitrate | 53 | $2,627 | $50 |
| Metoprolol | 84 | $1,928 | $23 |
| Rosuvastatin | 21 | $1,239 | $59 |
| Losartan | 143 | $1,228 | $9 |
| Amlodipine Besylate | 107 | $1,142 | $11 |
| Bumetanide | 11 | $1,137 | $103 |
| Clopidogrel | 89 | $985 | $11 |
| Lisinopril | 85 | $950 | $11 |
| Metoprolol | 108 | $933 | $9 |
| Diltiazem 24hr Er (Cd) | 28 | $910 | $32 |
| Carvedilol | 114 | $868 | $8 |
| Warfarin | 49 | $824 | $17 |
| Digoxin | 23 | $772 | $34 |
| Diltiazem | 20 | $608 | $30 |
| Isosorbide Mononitrate Er | 25 | $558 | $22 |
| Furosemide | 92 | $403 | $4 |
| Hydralazine | 21 | $375 | $18 |
| Cartia Xt | 16 | $358 | $22 |
| Spironolactone | 58 | $324 | $6 |
| Pantoprazole | 24 | $299 | $12 |
| Simvastatin | 19 | $215 | $11 |
| Omeprazole | 14 | $194 | $14 |
| Pravastatin | 12 | $193 | $16 |
| Famotidine | 18 | $122 | $7 |
2017: 28 drugs
| Eliquis | 58 | $26,503 | $457 |
| Brilinta | 51 | $21,821 | $428 |
| Pradaxa | 21 | $11,493 | $547 |
| Entresto | 14 | $8,504 | $607 |
| Atorvastatin | 174 | $1,825 | $10 |
| Digoxin | 27 | $1,069 | $40 |
| Metoprolol | 42 | $1,021 | $24 |
| Diltiazem 24hr Er | 17 | $897 | $53 |
| Warfarin | 84 | $809 | $10 |
| Carvedilol | 110 | $705 | $6 |
| Cartia Xt | 29 | $698 | $24 |
| Metoprolol | 100 | $685 | $7 |
| Isosorbide Dinitrate | 18 | $673 | $37 |
| Losartan | 99 | $669 | $7 |
| Amlodipine Besylate | 86 | $629 | $7 |
| Pantoprazole | 37 | $623 | $17 |
| Valsartan | 13 | $511 | $39 |
| Clopidogrel | 37 | $484 | $13 |
| Lisinopril | 82 | $483 | $6 |
| Levothyroxine | 12 | $379 | $32 |
| Hydralazine | 17 | $360 | $21 |
| Furosemide | 57 | $224 | $4 |
| Isosorbide Mononitrate Er | 12 | $205 | $17 |
| Pravastatin | 19 | $202 | $11 |
| Simvastatin | 21 | $178 | $8 |
| Omeprazole | 16 | $160 | $10 |
| Spironolactone | 22 | $133 | $6 |
| Famotidine | 19 | $75 | $4 |
2016: 26 drugs
| Eliquis | 35 | $14,619 | $418 |
| Brilinta | 22 | $9,115 | $414 |
| Pradaxa | 21 | $8,246 | $393 |
| Atorvastatin | 110 | $1,698 | $15 |
| Losartan | 59 | $725 | $12 |
| Digoxin | 23 | $622 | $27 |
| Metoprolol | 32 | $572 | $18 |
| Clopidogrel | 56 | $543 | $10 |
| Carvedilol | 67 | $529 | $8 |
| Chlorthalidone | 21 | $527 | $25 |
| Isosorbide Dinitrate | 12 | $506 | $42 |
| Metoprolol | 75 | $493 | $7 |
| Warfarin | 60 | $488 | $8 |
| Valsartan | 12 | $417 | $35 |
| Amlodipine Besylate | 67 | $394 | $6 |
| Pantoprazole | 30 | $388 | $13 |
| Isosorbide Mononitrate Er | 14 | $348 | $25 |
| Lisinopril | 61 | $320 | $5 |
| Levothyroxine | 15 | $300 | $20 |
| Furosemide | 37 | $189 | $5 |
| Diltiazem 24hr Cd | 11 | $142 | $13 |
| Spironolactone | 13 | $121 | $9 |
| Simvastatin | 15 | $108 | $7 |
| Omeprazole | 19 | $102 | $5 |
| Clonidine | 17 | $93 | $5 |
| Famotidine | 12 | $79 | $7 |
2015: 22 drugs
| Brilinta | 30 | $9,454 | $315 |
| Pradaxa | 23 | $8,367 | $364 |
| Atorvastatin | 118 | $1,853 | $16 |
| Losartan | 71 | $713 | $10 |
| Diltiazem 24hr Er | 14 | $677 | $48 |
| Sildenafil | 12 | $629 | $52 |
| Carvedilol | 86 | $621 | $7 |
| Potassium Chloride | 18 | $606 | $34 |
| Clopidogrel | 56 | $593 | $11 |
| Metoprolol | 84 | $569 | $7 |
| Warfarin | 53 | $567 | $11 |
| Valsartan | 16 | $518 | $32 |
| Levothyroxine | 29 | $422 | $15 |
| Pantoprazole | 37 | $411 | $11 |
| Metoprolol | 23 | $408 | $18 |
| Lisinopril | 50 | $390 | $8 |
| Isosorbide Mononitrate Er | 30 | $379 | $13 |
| Amlodipine Besylate | 49 | $288 | $6 |
| Furosemide | 70 | $266 | $4 |
| Simvastatin | 22 | $149 | $7 |
| Gabapentin | 14 | $142 | $10 |
| Metformin | 15 | $48 | $3 |
2014: 29 drugs
| Brilinta | 37 | $12,298 | $332 |
| Pradaxa | 21 | $10,099 | $481 |
| Eliquis | 14 | $7,828 | $559 |
| Xarelto | 13 | $3,816 | $294 |
| Atorvastatin | 175 | $3,215 | $18 |
| Carvedilol | 110 | $1,392 | $13 |
| Hydralazine | 31 | $1,282 | $41 |
| Clopidogrel | 51 | $1,252 | $25 |
| Warfarin | 91 | $948 | $10 |
| Amiodarone | 29 | $733 | $25 |
| Isosorbide Mononitrate Er | 45 | $711 | $16 |
| Lisinopril | 75 | $665 | $9 |
| Potassium Chloride | 19 | $633 | $33 |
| Losartan | 53 | $550 | $10 |
| Amlodipine Besylate | 75 | $512 | $7 |
| Pravastatin | 11 | $350 | $32 |
| Diltiazem 24hr Er | 11 | $348 | $32 |
| Levothyroxine | 22 | $335 | $15 |
| Pantoprazole | 26 | $334 | $13 |
| Metoprolol | 18 | $314 | $17 |
| Furosemide | 74 | $289 | $4 |
| Metoprolol | 37 | $256 | $7 |
| Omeprazole | 14 | $181 | $13 |
| Metformin | 15 | $156 | $10 |
| Simvastatin | 15 | $126 | $8 |
| Clonidine | 17 | $125 | $7 |
| Diltiazem | 13 | $112 | $9 |
| Gabapentin | 13 | $108 | $8 |
| Hydrochlorothiazide | 11 | $106 | $10 |
2013: 26 drugs
| Pradaxa | 16 | $4,782 | $299 |
| Atorvastatin | 161 | $4,774 | $30 |
| Brilinta | 13 | $3,864 | $297 |
| Effient | 12 | $2,972 | $248 |
| Clopidogrel | 40 | $1,580 | $39 |
| Carvedilol | 111 | $1,538 | $14 |
| Lovaza | 12 | $1,283 | $107 |
| Isosorbide Mononitrate Er | 67 | $1,254 | $19 |
| Warfarin | 138 | $1,251 | $9 |
| Hydralazine | 28 | $1,120 | $40 |
| Amlodipine Besylate | 83 | $661 | $8 |
| Lisinopril | 85 | $587 | $7 |
| Amiodarone | 25 | $395 | $16 |
| Pravastatin | 14 | $328 | $23 |
| Metoprolol | 44 | $313 | $7 |
| Clonidine | 22 | $277 | $13 |
| Losartan | 19 | $275 | $14 |
| Pantoprazole | 30 | $264 | $9 |
| Furosemide | 64 | $258 | $4 |
| Levothyroxine | 20 | $202 | $10 |
| Digox | 24 | $196 | $8 |
| Omeprazole | 14 | $187 | $13 |
| Diltiazem | 16 | $162 | $10 |
| Simvastatin | 21 | $158 | $8 |
| Bumetanide | 11 | $140 | $13 |
| Metolazone | 12 | $84 | $7 |
Money from drug and device companies
$27 in 2024
| 2024 | 1 | 1 | None | $27 |
| 2023 | 1 | 2 | None | $27 |
| 2022 | 1 | 2 | None | $125 |
| 2021 | 1 | 1 | None | $32 |
| 2020 | 1 | 1 | None | $14 |
| 2019 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Atricure | Atricure Cryoice Cryosphere Cryoablation System | $27 | 1 payment
|
See the published payment
| Atricure | Meals · 2024-09-30 | Atricure Cryoice Cryosphere Cryoablation System | $27 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $27
| Pfizer | Eliquis | $27 | 2 payments
|
2022: $125
| Abiomed | Impella | $125 | 2 payments
|
2021: $32
| AngioDynamics | Angiovac | $32 | 1 payment
|
2020: $14
| Medtronic Vascular | Reveal Linq | $14 | 1 payment
|
2019: $22
| Novartis Pharmaceuticals | Entresto | $22 | 1 payment
|
Checkups this office reported
14 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 60.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 93%That's most of the people this applied to. | 149 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 83%That's most of the people this applied to. | 160 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 41 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 185 |
| Colon cancer screeningEligible adults who got a colon cancer test | 0%That's few of the people this applied to. | 136 |
| Daily function assessedPatients whose ability to manage daily activities was assessed | 0%That's few of the people this applied to. | 27 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 252 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 40 |
See the other 6 measures
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 95%That's most of the people this applied to. Worse on this measure. | 40 |
| Medications listed in the chartVisits where the current medication list was documented | 65%That's more than half. | 474 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 192 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 40% | 126 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 81%That's most of the people this applied to. | 149 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 28%That's less than half. | 257 |
Professional record
- NPI
- 1750540621
- Licence
- CA A75847California A75847: Current · expires 2027-04-30
- Group
- California Cardiovascular Consultants · Washington Township Hospital District
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 1900 Mowry Ave., Suite 309, Fremont, CA, 94538
- NPI first listed
- 2008-06-05
- NPI last updated
- 2010-02-01
This is when the NPI record was last certified, not a medical board exam.